Georg Rainer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Georg Rainer has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Oliver Findl
7 shared publicationsBarbara Kiss
6 shared publicationsMichael Georgopoulos
6 shared publications- Oliver Findl
Department of Ophthalmology, University of Vienna, Austria
6 shared publications - Rupert Menapace
Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
6 shared publications Vanessa Petternel
6 shared publications
Latest Publications
- Open Access
- 1 January 2005
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (1) , 21-25
Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma
Aim: To investigate the effects of oral nimodipine on ocular haemodynamic parameters and colour contrast sensitivity in patients with normal tension glaucoma (NTG). Design: The study was performed in a randomised, placebo controlled, double masked, crossover design. Participants: Nimodipine (60 mg) or placebo was administered to 14 consecutive NTG patients. Methods: The effects or oral nimodipine or placebo on ocular and systemic haemodynamic parameters and colour contrast sensitivity along the tritan axis were studied two hours after administration. Optic nerve head blood flow (ONHBF) and choroidal blood flow (CHBF) were assessed with laser Doppler flowmetry. Ocular fundus pulsation amplitude (FPA) was measured with laser interferometry. Colour contrast sensitivity (CCS) was determined along the tritan colour axis. Main outcome measures: ONHBF, CHBF, FPA, intraocular pressure and CCS were assessed in patients with NTG. Results: Mean ocular FPA increased by 14% (SD 14%) (p = 0.0008), ONHBF by 18% (SD 16%) (p = 0.0031), and CHBF by 12% (SD 14%) (pConclusions: The results indicate that nimodipine increases ONH and choroidal blood flow in NTG patients and improves CCS. The latter effect does not, however, seem to be a direct consequence of the blood flow improvement.
- 1 January 2005
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (1) , 21-25
Open AccessEffect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma
Aim: To investigate the effects of oral nimodipine on ocular haemodynamic parameters and colour contrast sensitivity in patients with normal tension glaucoma (NTG). Design: The study was performed in a randomised, placebo controlled, double masked, crossover design. Participants: Nimodipine (60 mg) or placebo was administered to 14 consecutive NTG patients. Methods: The effects or oral nimodipine or placebo on ocular and systemic haemodynamic parameters and colour contrast sensitivity along the tritan axis were studied two hours after administration. Optic nerve head blood flow (ONHBF) and choroidal blood flow (CHBF) were assessed with laser Doppler flowmetry. Ocular fundus pulsation amplitude (FPA) was measured with laser interferometry. Colour contrast sensitivity (CCS) was determined along the tritan colour axis. Main outcome measures: ONHBF, CHBF, FPA, intraocular pressure and CCS were assessed in patients with NTG. Results: Mean ocular FPA increased by 14% (SD 14%) (p = 0.0008), ONHBF by 18% (SD 16%) (p = 0.0031), and CHBF by 12% (SD 14%) (pConclusions: The results indicate that nimodipine increases ONH and choroidal blood flow in NTG patients and improves CCS. The latter effect does not, however, seem to be a direct consequence of the blood flow improvement.
- 30 November 2004
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 221 (S 7) , 7_V
Einfluss antiglaukomatöser Therapie auf die okuläre Zirkulation
Hintergrund: Erhöhter Intraokulardruck ist der wichtigste Risikofaktor für Glaukom. In den letzten Jahren wurde in mehreren Studien gezeigt, dass eine Reduktion des Augeninnendrucks zu einer Reduktion der Progression des Gesichtsfeldverlustes führt. Neben dem Intraokulardruck spielen jedoch auch andere Faktoren, wie reduzierter okulärer Blutfluss, eine Rolle. Methoden: In dieser randomisierten Doppelblindstudie in zwei Parallelgruppen wurden Patienten mit primärem Ofenwinkelglaukom oder okulärer Hypertension eingeschlossen. Siebzig Patienten bekamen Dorzolamid und 70 Patienten Timolol über jeweils 6 Monate. Die Durchblutung in der Papille wurde mittels Heidelberg Retina Flowmeter gemessen, der pulsatile Anteil der Aderhautdurchblutung mittels laserinterferometrischer Messung von Funduspulsationen. Resultate: Die intraokulardrucksenkende Wirkung von Timolol und Dorzolamid war vergleichbar. Dorzolamid, nicht aber Timolol, erhöhte die Durchblutung an der Papille und die okuläre Funduspulsationsamplitude nach 6 Monaten Therapie. Schlussfolgerungen: Dorzolamid ist die einzig zugelassene Substanz, für die ein positiver Effekt auf die Augendurchblutung in einer größeren Studie gezeigt ist. Dieses Ergebnis ist insofern relevant, da reduzierter okulärer Perfusionsdruck und reduzierte Augendurchblutung Risikofaktoren für Glaukom darstellen.
- 30 November 2004
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 221 (S 7) , 7_V
Einfluss antiglaukomatöser Therapie auf die okuläre Zirkulation
Hintergrund: Erhöhter Intraokulardruck ist der wichtigste Risikofaktor für Glaukom. In den letzten Jahren wurde in mehreren Studien gezeigt, dass eine Reduktion des Augeninnendrucks zu einer Reduktion der Progression des Gesichtsfeldverlustes führt. Neben dem Intraokulardruck spielen jedoch auch andere Faktoren, wie reduzierter okulärer Blutfluss, eine Rolle. Methoden: In dieser randomisierten Doppelblindstudie in zwei Parallelgruppen wurden Patienten mit primärem Ofenwinkelglaukom oder okulärer Hypertension eingeschlossen. Siebzig Patienten bekamen Dorzolamid und 70 Patienten Timolol über jeweils 6 Monate. Die Durchblutung in der Papille wurde mittels Heidelberg Retina Flowmeter gemessen, der pulsatile Anteil der Aderhautdurchblutung mittels laserinterferometrischer Messung von Funduspulsationen. Resultate: Die intraokulardrucksenkende Wirkung von Timolol und Dorzolamid war vergleichbar. Dorzolamid, nicht aber Timolol, erhöhte die Durchblutung an der Papille und die okuläre Funduspulsationsamplitude nach 6 Monaten Therapie. Schlussfolgerungen: Dorzolamid ist die einzig zugelassene Substanz, für die ein positiver Effekt auf die Augendurchblutung in einer größeren Studie gezeigt ist. Dieses Ergebnis ist insofern relevant, da reduzierter okulärer Perfusionsdruck und reduzierte Augendurchblutung Risikofaktoren für Glaukom darstellen.
- 1 May 2004
- Published by Elsevier in Ophthalmology
- Vol. 111 (5) , 875-879
Central corneal thickness measurements with partial coherence interferometry, ultrasound, and the Orbscan system
- 1 May 2004
- Published by Elsevier in Ophthalmology
- Vol. 111 (5) , 875-879
Central corneal thickness measurements with partial coherence interferometry, ultrasound, and the Orbscan system
- 18 February 2004
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 221 (S 1) , KV46
Vergleich des Nachstarverhaltens zweier Acryl-Intraokularlinsen mit unterschiedlichem Haptikdesign: Acrysof SA60AT vs. Acrysof MA60BM
Hintergrund: Ziel dieser Studie war es, das Nachstarverhalten zweier Acryllinsen mit unterschiedlichem Haptikdesign (dreiteilige Acrysof MA60BM vs. einteilige Acrysof SA60AT) zu vergleichen. Patienten und Methoden: In diese prospektive, randomisierte Studie wurden 54 Patienten mit beidseitiger Katarakt inkludiert. Jedem Patienten wurde in das eine Auge eine MA60BM-Linse und in das andere Auge eine SA60AT-Linse implantiert. Die Untersuchungszeitpunkte waren 1 Woche, 1 Monat, 6 Monate, 1 Jahr und 2 Jahre nach der Operation. Das Ausmaß der Nachstarbildung wurde subjektiv an der Spaltlampe und objektiv mithilfe digitaler Retroilluminationsaufnahmen und eines automatisierten Bildanalysesystems (AQUA-Software) evaluiert. Ergebnisse: Ein Jahr postoperativ zeigten die Augen mit MA60BM-Linsen signifikant weniger regeneratorischen Nachstar. Der mittlere AQUA-Score betrug 1,5 für die MA60BM-Augen und 2,0 für die SA60AT-Augen (Skala: 0–10; pSchlussfolgerung: Die dreiteilige Acrysof-Linse führt im Vergleich zur einteiligen Acrysof-Linse innerhalb des ersten postoperativen Jahres zu einer geringeren Nachstarbildung. 2 Jahre postoperativ gibt es jedoch keinen signifikanten Unterschied zwischen den beiden Acryllinsen.
- 18 February 2004
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 221 (S 1) , KV46
Vergleich des Nachstarverhaltens zweier Acryl-Intraokularlinsen mit unterschiedlichem Haptikdesign: Acrysof SA60AT vs. Acrysof MA60BM
Hintergrund: Ziel dieser Studie war es, das Nachstarverhalten zweier Acryllinsen mit unterschiedlichem Haptikdesign (dreiteilige Acrysof MA60BM vs. einteilige Acrysof SA60AT) zu vergleichen. Patienten und Methoden: In diese prospektive, randomisierte Studie wurden 54 Patienten mit beidseitiger Katarakt inkludiert. Jedem Patienten wurde in das eine Auge eine MA60BM-Linse und in das andere Auge eine SA60AT-Linse implantiert. Die Untersuchungszeitpunkte waren 1 Woche, 1 Monat, 6 Monate, 1 Jahr und 2 Jahre nach der Operation. Das Ausmaß der Nachstarbildung wurde subjektiv an der Spaltlampe und objektiv mithilfe digitaler Retroilluminationsaufnahmen und eines automatisierten Bildanalysesystems (AQUA-Software) evaluiert. Ergebnisse: Ein Jahr postoperativ zeigten die Augen mit MA60BM-Linsen signifikant weniger regeneratorischen Nachstar. Der mittlere AQUA-Score betrug 1,5 für die MA60BM-Augen und 2,0 für die SA60AT-Augen (Skala: 0–10; pSchlussfolgerung: Die dreiteilige Acrysof-Linse führt im Vergleich zur einteiligen Acrysof-Linse innerhalb des ersten postoperativen Jahres zu einer geringeren Nachstarbildung. 2 Jahre postoperativ gibt es jedoch keinen signifikanten Unterschied zwischen den beiden Acryllinsen.
- 18 February 2004
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 221 (S 1) , V129
Postoperativer Augendruck nach Kleinschnittkataraktchirurgie mit primärer posterioren Kapsulorhexis
Hintergrund: In der frühpostoperativen Phase nach Kataraktoperation kommt es häufig zu Augendrucksteigerungen. Das Ziel dieser Studie war es, den postoperativen Augendruckverlauf nach Kataraktchirurgie mit primärer posterioren Kapsulorhexis (PPCCC) zu untersuchen. Patienten und Methoden: In dieser prospektiven, randomisierten Studie wurden 50 Augen von 25 konsekutiven Patienten mit altersbedingter beidseitiger Katarakt evaluiert. An einem Auge wurde eine Kataraktoperation mit PPCCC (Methylcellulose 2% für Phako, Na-Hyaluronat 1% für PPCCC & IOL-Implantation), am anderen Auge eine Standardkataraktoperation (Methylcellulose 2% für Phako & IOL-Implantation) durchgeführt. Nach Implantation einer faltbaren Acryl-IOL wurde die viskoelastische Substanz möglichst zur Gänze entfernt. Der Augendruck wurde sowohl präoperativ, als auch 6, 20–24 Stunden und 1 Woche nach der Kataraktoperation gemessen. Ergebnisse: Die mittleren Augendrucksteigerungen im Vergleich zum präoperativen Wert betrugen 11.1 bzw. 4.9mm Hg nach 6 Stunden (pSchlussfolgerung: In der frühpostoperativen Phase nach Kataraktoperation mit PPCCC kommt es, wahrscheinlich durch das zunächst im Glaskörperraum verbleibende Na-Hyaluronat, im Vergleich zur Standardkataraktoperation zu signifikant höheren Augendrucksteigerungen.
- 18 February 2004
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 221 (S 1) , V129
Postoperativer Augendruck nach Kleinschnittkataraktchirurgie mit primärer posterioren Kapsulorhexis
Hintergrund: In der frühpostoperativen Phase nach Kataraktoperation kommt es häufig zu Augendrucksteigerungen. Das Ziel dieser Studie war es, den postoperativen Augendruckverlauf nach Kataraktchirurgie mit primärer posterioren Kapsulorhexis (PPCCC) zu untersuchen. Patienten und Methoden: In dieser prospektiven, randomisierten Studie wurden 50 Augen von 25 konsekutiven Patienten mit altersbedingter beidseitiger Katarakt evaluiert. An einem Auge wurde eine Kataraktoperation mit PPCCC (Methylcellulose 2% für Phako, Na-Hyaluronat 1% für PPCCC & IOL-Implantation), am anderen Auge eine Standardkataraktoperation (Methylcellulose 2% für Phako & IOL-Implantation) durchgeführt. Nach Implantation einer faltbaren Acryl-IOL wurde die viskoelastische Substanz möglichst zur Gänze entfernt. Der Augendruck wurde sowohl präoperativ, als auch 6, 20–24 Stunden und 1 Woche nach der Kataraktoperation gemessen. Ergebnisse: Die mittleren Augendrucksteigerungen im Vergleich zum präoperativen Wert betrugen 11.1 bzw. 4.9mm Hg nach 6 Stunden (pSchlussfolgerung: In der frühpostoperativen Phase nach Kataraktoperation mit PPCCC kommt es, wahrscheinlich durch das zunächst im Glaskörperraum verbleibende Na-Hyaluronat, im Vergleich zur Standardkataraktoperation zu signifikant höheren Augendrucksteigerungen.
- 1 September 2003
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 29 (9) , 1748-1752
Effect of a fixed dorzolamide–timolol combination on intraocular pressure after small-incision cataract surgery with Viscoat
To evaluate the effect of a fixed dorzolamide-timolol combination (Cosopt) on intraocular pressure (IOP) after small-incision cataract surgery with sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat). Department of Ophthalmology, University of Vienna, Vienna, Austria. This prospective randomized study comprised 76 eyes of 38 patients scheduled for small-incision cataract surgery in both eyes. Patients were randomized to receive 1 drop of the fixed dorzolamide-timolol combination in 1 eye or no treatment (control) immediately after cataract surgery. The fellow eye received the other assigned treatment. Cataract surgery was performed with Viscoat in an identical fashion in both eyes. The IOP was measured preoperatively and 6 hours, 20 to 24 hours, and 1 week postoperatively. Six hours after surgery, the mean increase in IOP was significantly lower in the dorzolamide-timolol group than in the control group (4.3 mm Hg +/- 5.6 [SD] versus 8.4 +/- 6.1 mm Hg; P =.003). Two eyes in the dorzolamide-timolol group and 9 in the control group had IOP spikes of 30 mm Hg or higher (P =.022). Twenty to 24 hours after surgery, the mean IOP change was -2.6 +/- 3.3 mm Hg in the dorzolamide-timolol group and 1.5 +/- 3.2 mm Hg in the control group (P<.001). The fixed dorzolamide-timolol combination was effective in reducing IOP 6 hours and 20 to 24 hours after cataract surgery. However, it did not prevent Viscoat-induced IOP spikes of 30 mm Hg or higher.
- 1 September 2003
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 29 (9) , 1748-1752
Effect of a fixed dorzolamide–timolol combination on intraocular pressure after small-incision cataract surgery with Viscoat
To evaluate the effect of a fixed dorzolamide-timolol combination (Cosopt) on intraocular pressure (IOP) after small-incision cataract surgery with sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat). Department of Ophthalmology, University of Vienna, Vienna, Austria. This prospective randomized study comprised 76 eyes of 38 patients scheduled for small-incision cataract surgery in both eyes. Patients were randomized to receive 1 drop of the fixed dorzolamide-timolol combination in 1 eye or no treatment (control) immediately after cataract surgery. The fellow eye received the other assigned treatment. Cataract surgery was performed with Viscoat in an identical fashion in both eyes. The IOP was measured preoperatively and 6 hours, 20 to 24 hours, and 1 week postoperatively. Six hours after surgery, the mean increase in IOP was significantly lower in the dorzolamide-timolol group than in the control group (4.3 mm Hg +/- 5.6 [SD] versus 8.4 +/- 6.1 mm Hg; P =.003). Two eyes in the dorzolamide-timolol group and 9 in the control group had IOP spikes of 30 mm Hg or higher (P =.022). Twenty to 24 hours after surgery, the mean IOP change was -2.6 +/- 3.3 mm Hg in the dorzolamide-timolol group and 1.5 +/- 3.2 mm Hg in the control group (P<.001). The fixed dorzolamide-timolol combination was effective in reducing IOP 6 hours and 20 to 24 hours after cataract surgery. However, it did not prevent Viscoat-induced IOP spikes of 30 mm Hg or higher.
- 1 December 2002
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 28 (12) , 2142-2145
Comparison of ultrasound pachymetry and partial coherence interferometry in the measurement of central corneal thickness
To compare central corneal thickness (CCT) measurements obtained with 3 ultrasound pachymeters and with partial coherence interferometry (PCI) and evaluate the effect of repeated contact by a pachymetry probe on corneal thickness. Department of Ophthalmology, University of Vienna, Vienna, Austria. Central corneal thickness was measured in 20 eyes of 20 healthy volunteers with 3 different ultrasound pachymeters (DGH 500, DGH Technology Inc.; SP 2000, Tomey Inc.; Paxis, Biovision Inc.) and with PCI. In each eye, 5 measurements with PCI were followed by 5 measurements with each ultrasound pachymetry device and another 5 measurements with PCI. The mean CCT measured with the DGH 500, SP 2000, and Paxis was 541.0 microm, 539.2 microm, and 545.1 microm, respectively. Although the differences among the 3 ultrasound pachymetry devices were within 6.0 microm, they were statistically significant (P<.05). The PCI measurements were significantly smaller (P <.05) than the ultrasound measurements: 518.8 microm before and 517.5 microm after repeated contact with the ultrasound pachymetry probe (P <.05). The mean precision (standard deviation) was 0.77 microm for PCI and between 2.40 microm and 3.58 microm for ultrasound pachymetry measurements. The correlation coefficients for the intraobserver variability were 0.999 for PCI and between 0.987 and 0.995 for ultrasound pachymetry measurements. Partial coherence interferometry was the more precise method of measuring CCT and had better intraobserver variability. Repeated contact by a pachymetry probe reduced corneal thickness by 1.3 microm. However, the reason for the smaller measurements with PCI than with ultrasound pachymetry remains unclear.
- 1 December 2002
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 28 (12) , 2142-2145
Comparison of ultrasound pachymetry and partial coherence interferometry in the measurement of central corneal thickness
To compare central corneal thickness (CCT) measurements obtained with 3 ultrasound pachymeters and with partial coherence interferometry (PCI) and evaluate the effect of repeated contact by a pachymetry probe on corneal thickness. Department of Ophthalmology, University of Vienna, Vienna, Austria. Central corneal thickness was measured in 20 eyes of 20 healthy volunteers with 3 different ultrasound pachymeters (DGH 500, DGH Technology Inc.; SP 2000, Tomey Inc.; Paxis, Biovision Inc.) and with PCI. In each eye, 5 measurements with PCI were followed by 5 measurements with each ultrasound pachymetry device and another 5 measurements with PCI. The mean CCT measured with the DGH 500, SP 2000, and Paxis was 541.0 microm, 539.2 microm, and 545.1 microm, respectively. Although the differences among the 3 ultrasound pachymetry devices were within 6.0 microm, they were statistically significant (P<.05). The PCI measurements were significantly smaller (P <.05) than the ultrasound measurements: 518.8 microm before and 517.5 microm after repeated contact with the ultrasound pachymetry probe (P <.05). The mean precision (standard deviation) was 0.77 microm for PCI and between 2.40 microm and 3.58 microm for ultrasound pachymetry measurements. The correlation coefficients for the intraobserver variability were 0.999 for PCI and between 0.987 and 0.995 for ultrasound pachymetry measurements. Partial coherence interferometry was the more precise method of measuring CCT and had better intraobserver variability. Repeated contact by a pachymetry probe reduced corneal thickness by 1.3 microm. However, the reason for the smaller measurements with PCI than with ultrasound pachymetry remains unclear.
- 1 August 2001
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 27 (8) , 1227-1231
Effect of topical brimonidine on intraocular pressure after small incision cataract surgery
To evaluate the effect of brimonidine 0.2% on intraocular pressure (IOP) after small incision cataract surgery. Department of Ophthalmology, University of Vienna, Vienna, Austria. This prospective randomized study comprised 80 eyes of 40 patients scheduled for small incision cataract surgery in both eyes. In each patient, 1 eye was randomly assigned to receive 1 drop of brimonidine 0.2% or no treatment (control) immediately after surgery. The fellow eye received the other assigned treatment. All patients had standardized surgery by the same surgeon with sodium hyaluronate 1%, a temporal 3.5 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable intraocular lens. The IOP was measured preoperatively as well as 6 and 20 to 24 hours and 1 week postoperatively. Six hours after surgery, the mean increase in IOP was 4.7 mm Hg +/- 6.1 (SD) in the brimonidine group and 4.6 +/- 5.3 mm Hg in the control group. In each group, 17 eyes (43%) had an IOP increase of 5 mm Hg or more. Twenty to 24 hours after surgery, the mean increase in IOP was 1.5 +/- 4.2 mm Hg in the brimonidine group and 1.6 +/- 4.4 mm Hg in the control group. There were no statistically significant between-group differences at any measurement. In both groups, IOP significantly increased 6 hours and 20 to 24 hours after small incision cataract surgery. Brimonidine 0.2% failed to reduce the IOP increase observed after small incision cataract surgery.
- 1 August 2001
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 27 (8) , 1227-1231
Effect of topical brimonidine on intraocular pressure after small incision cataract surgery
To evaluate the effect of brimonidine 0.2% on intraocular pressure (IOP) after small incision cataract surgery. Department of Ophthalmology, University of Vienna, Vienna, Austria. This prospective randomized study comprised 80 eyes of 40 patients scheduled for small incision cataract surgery in both eyes. In each patient, 1 eye was randomly assigned to receive 1 drop of brimonidine 0.2% or no treatment (control) immediately after surgery. The fellow eye received the other assigned treatment. All patients had standardized surgery by the same surgeon with sodium hyaluronate 1%, a temporal 3.5 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable intraocular lens. The IOP was measured preoperatively as well as 6 and 20 to 24 hours and 1 week postoperatively. Six hours after surgery, the mean increase in IOP was 4.7 mm Hg +/- 6.1 (SD) in the brimonidine group and 4.6 +/- 5.3 mm Hg in the control group. In each group, 17 eyes (43%) had an IOP increase of 5 mm Hg or more. Twenty to 24 hours after surgery, the mean increase in IOP was 1.5 +/- 4.2 mm Hg in the brimonidine group and 1.6 +/- 4.4 mm Hg in the control group. There were no statistically significant between-group differences at any measurement. In both groups, IOP significantly increased 6 hours and 20 to 24 hours after small incision cataract surgery. Brimonidine 0.2% failed to reduce the IOP increase observed after small incision cataract surgery.
- 1 May 2001
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 27 (5) , 706-710
Intraindividual comparison of the effects of a fixed dorzolamide–timolol combination and latanoprost on intraocular pressure after small incision cataract surgery
To compare the effect of a fixed dorzolamide-timolol combination with that of latanoprost on intraocular pressure (IOP) after small incision cataract surgery. Department of Ophthalmology, University of Vienna, Vienna, Austria. This prospective randomized study comprised 60 eyes of 30 patients scheduled for small incision cataract surgery in both eyes. The patients were randomly assigned to receive 1 drop of a fixed dorzolamide-timolol combination or latanoprost immediately after cataract surgery in the first eye. The second eye received the other antiglaucomatous agent. Cataract surgery was performed under sodium hyaluronate 1% with a temporal 3.5 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable intraocular lens. The IOP was measured preoperatively as well as 6 and 20 to 24 hours and 1 week postoperatively. Six hours after surgery, the mean IOP decreased by -0.8 mm Hg +/- 3.2 (SD) (P =.184) in the dorzolamide-timolol group and increased by 3.6 mm Hg +/- 3.5 (P <.001) in the latanoprost group. Twenty to 24 hours after surgery, the mean IOP decreased by -2.8 +/- 2.4 mm Hg (P <.001) in the dorzolamide-timolol group and increased by 0.6 +/- 3.5 mm Hg (P =.353) in the latanoprost group. The differences between groups were significant at 6 hours (P <.001) and 20 to 24 hours (P <.001). The fixed dorzolamide-timolol combination was more effective than latanoprost in reducing IOP after small incision cataract surgery. Only the fixed dorzolamide-timolol combination prevented a postoperative IOP increase and occasional IOP spikes of 30 mm Hg or higher.
- 1 May 2001
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 27 (5) , 706-710
Intraindividual comparison of the effects of a fixed dorzolamide–timolol combination and latanoprost on intraocular pressure after small incision cataract surgery
To compare the effect of a fixed dorzolamide-timolol combination with that of latanoprost on intraocular pressure (IOP) after small incision cataract surgery. Department of Ophthalmology, University of Vienna, Vienna, Austria. This prospective randomized study comprised 60 eyes of 30 patients scheduled for small incision cataract surgery in both eyes. The patients were randomly assigned to receive 1 drop of a fixed dorzolamide-timolol combination or latanoprost immediately after cataract surgery in the first eye. The second eye received the other antiglaucomatous agent. Cataract surgery was performed under sodium hyaluronate 1% with a temporal 3.5 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable intraocular lens. The IOP was measured preoperatively as well as 6 and 20 to 24 hours and 1 week postoperatively. Six hours after surgery, the mean IOP decreased by -0.8 mm Hg +/- 3.2 (SD) (P =.184) in the dorzolamide-timolol group and increased by 3.6 mm Hg +/- 3.5 (P <.001) in the latanoprost group. Twenty to 24 hours after surgery, the mean IOP decreased by -2.8 +/- 2.4 mm Hg (P <.001) in the dorzolamide-timolol group and increased by 0.6 +/- 3.5 mm Hg (P =.353) in the latanoprost group. The differences between groups were significant at 6 hours (P <.001) and 20 to 24 hours (P <.001). The fixed dorzolamide-timolol combination was more effective than latanoprost in reducing IOP after small incision cataract surgery. Only the fixed dorzolamide-timolol combination prevented a postoperative IOP increase and occasional IOP spikes of 30 mm Hg or higher.
- Open Access
- 1 February 2001
- Published by BMJ in British Journal of Ophthalmology
- Vol. 85 (2) , 139-142
Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents
AIM To evaluate the effects of the dispersive viscoelastic agents Ocucoat (hydroxypropyl methylcellulose 2%) and Viscoat (sodium chondroitin sulphate 4%–sodium hyaluronate 3%) on postoperative intraocular pressure (IOP) after bilateral small incision cataract surgery. METHODS This prospective, randomised study comprised 80 eyes of 40 consecutive patients with age related cataract in both eyes scheduled for bilateral small incision cataract surgery. The patients were randomly assigned to receive Ocucoat or Viscoat during cataract surgery of the first eye. The second eye was operated later and received the other viscoelastic agent. Cataract surgery was performed with a temporal 3.2 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable silicone intraocular lens. The IOP was measured preoperatively as well as 6 hours, 20–24 hours, and 1 week postoperatively. RESULTS At 6 hours after surgery the mean IOP increased by 4.6 (SD 5.1) mm Hg in the Ocucoat group (pCONCLUSION These findings indicate that Viscoat causes a significantly higher IOP increase and significantly more IOP spikes than Ocucoat in the early period after small incision cataract surgery.
- 1 February 2001
- Published by BMJ in British Journal of Ophthalmology
- Vol. 85 (2) , 139-142
Open AccessIntraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents
AIM To evaluate the effects of the dispersive viscoelastic agents Ocucoat (hydroxypropyl methylcellulose 2%) and Viscoat (sodium chondroitin sulphate 4%–sodium hyaluronate 3%) on postoperative intraocular pressure (IOP) after bilateral small incision cataract surgery. METHODS This prospective, randomised study comprised 80 eyes of 40 consecutive patients with age related cataract in both eyes scheduled for bilateral small incision cataract surgery. The patients were randomly assigned to receive Ocucoat or Viscoat during cataract surgery of the first eye. The second eye was operated later and received the other viscoelastic agent. Cataract surgery was performed with a temporal 3.2 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable silicone intraocular lens. The IOP was measured preoperatively as well as 6 hours, 20–24 hours, and 1 week postoperatively. RESULTS At 6 hours after surgery the mean IOP increased by 4.6 (SD 5.1) mm Hg in the Ocucoat group (pCONCLUSION These findings indicate that Viscoat causes a significantly higher IOP increase and significantly more IOP spikes than Ocucoat in the early period after small incision cataract surgery.